Psoriatic Arthritis
News
Analysis of PsA guidelines reveals much room for improvement on conflicts of interest
Researchers show that a majority of the authors of the most recent psoriatic arthritis clinical practice guidelines from the American College of...
Conference Coverage
Sex differences seen in inflammatory arthritis health care use
Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher...
News
Apremilast may have some cardiometabolic benefits in patients with psoriasis
The trial does help answer the question of whether apremilast can induce weight loss ... something that earlier trials suggested.
News
Psoriasis, psoriatic arthritis insurance coverage remains restrictive
A database review showed restrictive coverage of specialty medications for psoriatic disease beyond the label indications.
News
Apremilast alleviates severe psoriasis in some children, data show
“In this randomized, placebo-controlled trial, oral apremilast demonstrated effectiveness and was well tolerated.”
News
Brodalumab suicide risk similar to other biologics, postmarket study finds
The researchers extracted data through the end of 2021 on the number of completed suicides for brodalumab and ten other biologics approved for...
Article
Elbow tenderness and swollen joints
News
Autoimmune diseases linked to spike in post-MI events
“People with rheumatic arthritis, when they have a heart attack, are less likely to get the standard kind of treatments and have worse outcomes...
News
Sustained response at 2 years reported for newly approved oral psoriasis agent
Long-term results with the JAK inhibitor for psoriasis show responses persist.
News
FDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasis
Approval was based on the results of two phase 3 trials of almost 1,700 adults with moderate to severe plaque psoriasis.